Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
STAAR Surgical Company
STAACurrent price
32.38 USD
+2.41 USD (+8.04%)
Last closed
29.97 USD
Company
www.staar.com
ISIN
US8523123052
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
NASDAQ
Capitalization
1 530 736 768 USD
Yield for 12 month
-22.92 %
1Y
3Y
5Y
10Y
15Y
STAA
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California. Address: 25651 Atlantic Ocean Drive, Lake Forest, CA, United States, 92630
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
50.49 USDP/E ratio
94.303Dividend Yield
–Current Year
+322 415 000 USD
Last Year
+284 391 000 USD
Current Quarter
+99 005 000 USD
Last Quarter
+77 356 000 USD
Current Year
+252 651 000 USD
Last Year
+223 383 000 USD
Current Quarter
+78 412 000 USD
Last Quarter
+61 035 000 USD
Key Figures STAA
1 year
3 years
5 years
10 years
EBITDA
33 268 000 USD
Operating Margin TTM
PE Ratio
94.303
Return On Assets TTM
3.67 %
PEG Ratio
-4.89
Return On Equity TTM
4.36 %
Wall Street Target Price
50.49 USD
Revenue TTM
332 942 016 USD
Book Value
8.32 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
7.3 %
Dividend Yield
–
Gross Profit TTM
223 383 000 USD
Earnings per share
0.33 USD
Diluted Eps TTM
0.33 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
25 %
Profit Margin
4.99 %
Dividend Analytics STAA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History STAA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:2
Payout Ratio
–
Last Split Date
18.05.1992
Dividend Date
–
Stock Valuation STAA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
94.303
Forward PE
625
Enterprise Value Revenue
4.0046
Price Sales TTM
4.5976
Enterprise Value EBITDA
42.1512
Price Book MRQ
3.7453
Financials STAA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators STAA
For 52 weeks
26.66 USD
52.68 USD
50 Day MA
39.39 USD
Shares Short Prior Month
4 347 120
200 Day MA
37.63 USD
Short Ratio
4.5
Shares Short
3 912 351
Short Percent
15.88 %
BeatStart